Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.
about
B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?Gene therapy on the moveLong-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyImproving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.Intrathymic transplantation of bone marrow-derived progenitors provides long-term thymopoiesis.B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a reviewTransplantation immunology: solid organ and bone marrow.Radiosensitive severe combined immunodeficiency disease.Hematopoietic cell transplantation for treatment of primary immune deficiencies.Hematopoietic stem cell transplantation for primary immunodeficiencies.Long-lasting production of new T and B cells and T-cell repertoire diversity in patients with primary immunodeficiency who had undergone stem cell transplantation: a single-centre experience.Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningIL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?Post-transplantation B cell function in different molecular types of SCIDThe natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis.SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.The case for mandatory newborn screening for severe combined immunodeficiency (SCID).T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders.Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsoRecommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumDiagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.Endocrine complications in primary immunodeficiency diseases in Japan.Hematopoietic stem cell transplantation for primary immunodeficiency diseases.Long term outcomes of severe combined immunodeficiency: therapy implications.Severe combined immunodeficiencies and related disorders.Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan.Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.
P2860
Q26828763-FF0A162E-EF09-49EC-80E6-DD4B03E6129AQ27007012-4043295F-8ECB-48B0-99D8-D731BC172C1AQ33395718-C08D418E-E5F6-4675-9EDF-199B72F45183Q33700953-5395CE9C-4E2A-4458-84BB-87CE4A555658Q33722691-25FBF904-54F7-433E-8174-FE1E6E5C3BCEQ33803725-9D05D361-CFD3-4AD6-8415-93ACB68449E3Q33803804-AFF2B1DF-8D5A-4FBC-93A0-F3DA944D1092Q34095701-2A75EFC7-F8F8-4DF5-AF38-64E4A065CAEEQ34383907-79D58063-0841-4E13-B1D3-C5AE541B1044Q34630754-C1A60657-EFCB-4143-A03E-F444D0912342Q34729193-88E0662E-7679-4D13-A174-986912AB1079Q35728637-5A8F7FC3-3D4E-4902-B8F7-78219698E130Q35917162-F3D867E0-3D83-48B6-BEAB-64984CFB495CQ35975844-CC4D9E1D-8BE7-4DFD-A5CF-C0E41B00070FQ36078279-CFA4D32A-C08A-4168-9E81-0A718327A829Q36269199-AABEADF7-F799-41CF-AEFF-583D59E4E580Q36546267-F64F6D18-FFD6-4185-81A6-8D27BDEECD84Q37201035-EAEE0679-19E8-4B27-A940-44B81FC81738Q37233057-E014E91D-9C9F-453A-828E-9854BB63BAC5Q37306608-83FACB23-B97E-4E37-B204-7AD5046B9B0EQ37442494-AEF77432-E64E-44BC-8042-454F71B26A9CQ37635576-CFA7E6F0-A409-41B5-AB49-90719607F08FQ37678465-66DDB9B9-1A31-4148-9E9F-FA3AEAFBE601Q38201349-39824604-0142-4AAA-AA72-FB4EE70482B1Q38766552-20298D5A-5F4A-4BDA-AED3-519E0A75174BQ38772827-D96E80CF-1408-4F82-B18C-54DF4B3A153DQ39289010-35F9D734-233C-4EDF-963B-A61C6BE62D39Q40533048-B33D48C9-5606-4E85-B680-1DF6F8FF864BQ41070585-43F7C1FB-5647-4BBA-86FC-0CF0746FA571Q43223358-91D6F930-10E7-49C1-9718-B7D0177C5F7DQ44641781-E2BB198E-4A57-4FC6-8C47-58738B634440Q44797357-6D564F59-DE25-4269-8F62-A8894BD44F94Q45872036-7F133BC6-855A-46FF-A2A5-F7DC8DA6C5D3Q45886049-A3FE3851-217E-446F-B391-F5940AD86F99Q48027176-6F55C8B5-1B20-428B-B18E-561AE91689DCQ51867494-F2603D2E-A17A-47A7-A220-F31BFBC631ADQ55334301-C0C36ABF-751D-44BD-B595-0FDF5DE31E09
P2860
Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@en
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@nl
type
label
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@en
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@nl
prefLabel
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@en
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@nl
P2093
P1476
Long-term immune reconstitutio ...... evere T-cell immunodeficiency.
@en
P2093
Arnalda Lanfranchi
Concetta Forino
Evelina Mazzolari
Fulvio Porta
Luigi D Notarangelo
Luisa Imberti
Sara Guerci
P304
P356
10.1016/J.JACI.2007.08.007
P407
P577
2007-09-07T00:00:00Z